Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022;17(4):227-239.
doi: 10.2174/1574887117666220811143426.

Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery

Affiliations
Review

Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery

Francesca Di Candido. Rev Recent Clin Trials. 2022.

Abstract

Inflammatory Bowel Diseases (IBDs) are chronic, relapsing and disabling diseases that affect the gastrointestinal tract. This relapsing course is often unpredictable with severe flares and the need for intensive medical treatment, hospitalization, or emergent/urgent surgery, all of which significantly impact patients' quality of life (QoL). QoL in IBD patients is significantly lower than in the general population, and depression and anxiety have been shown to have a higher prevalence than in healthy individuals, especially during disease flares. Complications requiring hospitalization and repeated surgeries are not uncommon during the disease course and significantly affect QoL in IBD patients. Patient-reported outcome measures (PROMs) can be used to measure the impact of chronic disease on QoL from the patient's perspective. The use of PROMs in IBD patients undergoing surgery could help to investigate the impact of the surgical procedure on QoL and determine whether there is any improvement or worsening. This review summarizes the use of PROMs to assess QoL after various surgical procedures required for IBD treatment.

Keywords: Quality of life; crohn’s disease; inflammatory bowel disease; outcome measure; patient reported; psychological distress; ulcerative colitis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Burisch J.; Munkholm P,; The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 2015,50(8),942-51 - DOI - PubMed
    1. Levine JS,; Burakoff R.; Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011,7(4),235-41 - PubMed
    1. Simian D.; Quijada M.I.; Lubascher J.; Acuña R.; Quera R.; Treatment of inflammatory bowel disease with infliximab: Experience in 25 patients. Rev Med Chil 2013,141(9),1158-65 - DOI - PubMed
    1. Cohen R.D.; The quality of life in patients with Crohn’s disease. Aliment Pharmacol Ther 2002,16(9),1603-9 - DOI - PubMed
    1. Rogala L.; Miller N.; Graff L.A.; Population-based controlled study of social support, self-perceived stress, activity and work issues, and access to health care in inflammatory bowel disease. Inflamm Bowel Dis 2008,14(4),526-35 - DOI - PubMed